HOME >> BIOLOGY >> NEWS
Paratek Pharmaceuticals presents multiple sclerosis data at Society for Neuroscience annual meeting

Paratek Pharmaceuticals, Inc. announced results of preclinical studies demonstrating that a new class of compounds, orally available non-antibacterial tetracyclines, has shown promising activity in a preclinical animal model of multiple sclerosis (MS). Affecting approximately two million people worldwide, MS is a chronic, inflammatory condition of the nervous system and the most common, non-traumatic, neurological disease in young adults. Dr. David McKenney, a Paratek scientist, will present the findings during an oral presentation at 2:30 p.m. PST (5:30 p.m. EST) today at Neuroscience 2004, the Society for Neuroscience's 34th Annual Meeting in San Diego.

For the first time, Paratek is presenting data showing that its non-antibacterial tetracycline compounds in a preclinical model of MS have efficacy comparable to minocycline, an antibiotic also in the tetracycline family. A previous clinical study directed by Dr. Luanne Metz at the University of Calgary has demonstrated disease protection in MS patients treated with minocycline. Unfortunately, long-term treatment with minocycline or any other broad-spectrum antibiotics causes many patients to experience intolerability related to antibiotic side effects. In today's presentation, Paratek will report that three non-antibacterial tetracycline compounds, with different structures, demonstrated activity in reducing limb paralysis in the preclinical EAE (Experimental Autoimmune Encephalomyelitis) model of MS. These compounds have no detectable antibacterial activity.

Paratek Pharmaceuticals, Inc. and Serono (virt-x: SEO and NYSE: SRA) announced today that they have entered into an agreement to discover, develop and commercialize an orally-available disease modifying treatment for multiple sclerosis (MS). The agreement covers the compounds for which Dr. McKenney presents data today.

Stuart Levy, Paratek's Vice Chairman, Chief Scientific Officer and Co-Founder, commented, "The clinica
'"/>

Contact: Katie Compa
kcompa@burnsmc.com
212-213-0006
Burns McClellan
27-Oct-2004


Page: 1 2

Related biology news :

1. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
2. Progenika Biopharma presents a biochip that guarantees safety in blood transfusions
3. SNM presents awards on Capitol Hill
4. ESA presents the sharpest ever satellite map of Earth
5. New book presents neurobiology from an evolutionary perspective
6. Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants
7. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
8. USGS presents a world of science at GSA in Philadelphia
9. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
10. DFG presents the 2006 MAK and BAT value list
11. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... (PRWEB) , ... October 18, 2018 , ... ... to home with the release of the world’s first beginner’s guide to genetic ... at home, school & in the makerspace" is written for teenagers, families, teachers, ...
(Date:10/16/2018)... ... October 16, 2018 , ... At five years old, Sam began ... tumor and instead, Sam’s veterinarian found that he had arthritis in his lower, or ... his owner placed him on supplements for the arthritis and monitored his activity. , ...
(Date:10/13/2018)... ... October 12, 2018 , ... ... MD, board certified in colorectal surgery, to its Medical Advisory Board. Joining the ... bring to uBiome his deep expertise in the surgical treatments of ulcerative colitis ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... (PRWEB) , ... October 04, 2018 , ... ... that it has received a Spine Technology Award from Orthopedics This Week during ... last week. The Power T Handle is a surgical instrument that delivers operating ...
(Date:10/5/2018)... ... October 04, 2018 , ... Shell’s Puget Sound Refinery recently ... purchase a high-tech machine that turns plastic into prosthesis. The Million Waves Project ... then processes the usable plastic and turns it into 3D printed prosthetic limbs ...
(Date:10/3/2018)... ... October 03, 2018 , ... Milwaukee Area Technical College (MATC), a public, ... from 3-7 p.m. in Room T129 in the T Building, 101 N. 6th St., ... Lab. A ribbon cutting and formal program will be held at 4 p.m. , ...
(Date:10/2/2018)... SOLON, Ohio (PRWEB) , ... October 02, 2018 ... ... been announced, and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was ... by World Oil and Gulf Energy Information, honor leading innovations in upstream oil ...
Breaking Biology Technology:
Cached News: